Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cancer Intelligence Care Systems is developing and supplying accelerator-based neutron irradiation devices for Boron Neutron Capture Therapy (BNCT), a novel radiotherapy that selectively kills cancer cells. The company's technology is being evaluated in Phase 1/2 basket trials for recurrent solid malignant thoracic tumors and has been used in clinical research targeting superficial FDG-PET positive tumors. Early-stage results focus on safety and efficacy of BNCT using their proprietary CICS-1 device combined with boron compounds such as SPM-011.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cancer Intelligence Care Systems.